BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34791703)

  • 21. Targeting a cryptic allosteric site for selective inhibition of the oncogenic protein tyrosine phosphatase Shp2.
    Chio CM; Lim CS; Bishop AC
    Biochemistry; 2015 Jan; 54(2):497-504. PubMed ID: 25519989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations.
    Bishop AC; Zhang XY; Lone AM
    Methods; 2007 Jul; 42(3):278-88. PubMed ID: 17532515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases.
    Yu ZH; Zhang ZY
    Chem Rev; 2018 Feb; 118(3):1069-1091. PubMed ID: 28541680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small molecule tools for functional interrogation of protein tyrosine phosphatases.
    He R; Zeng LF; He Y; Zhang S; Zhang ZY
    FEBS J; 2013 Jan; 280(2):731-50. PubMed ID: 22816879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?
    Dempke WCM; Uciechowski P; Fenchel K; Chevassut T
    Oncology; 2018; 95(5):257-269. PubMed ID: 29925063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptidomimetic competitive inhibitors of protein tyrosine phosphatases.
    Shen K; Qi L; Stiff L
    Curr Pharm Des; 2010; 16(28):3101-17. PubMed ID: 20687872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydroxyindole carboxylic acid-based inhibitors for receptor-type protein tyrosine protein phosphatase beta.
    Zeng LF; Zhang RY; Bai Y; Wu L; Gunawan AM; Zhang ZY
    Antioxid Redox Signal; 2014 May; 20(14):2130-40. PubMed ID: 24180557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-Based Virtual Screening of Protein Tyrosine Phosphatase Inhibitors: Significance, Challenges, and Solutions.
    Reddy RH; Kim H; Cha S; Lee B; Kim YJ
    J Microbiol Biotechnol; 2017 May; 27(5):878-895. PubMed ID: 28238001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitogen-Activated Protein Kinase Phosphatases: No Longer Undruggable?
    Shillingford SR; Bennett AM
    Annu Rev Pharmacol Toxicol; 2023 Jan; 63():617-636. PubMed ID: 36662585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Covalent inhibition of protein tyrosine phosphatases.
    Ruddraraju KV; Zhang ZY
    Mol Biosyst; 2017 Jun; 13(7):1257-1279. PubMed ID: 28534914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTP1B: from the sidelines to the front lines!
    Tonks NK
    FEBS Lett; 2003 Jul; 546(1):140-8. PubMed ID: 12829250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput methods in identification of protein tyrosine phosphatase inhibitors and activators.
    Mattila E; Ivaska J
    Anticancer Agents Med Chem; 2011 Jan; 11(1):141-50. PubMed ID: 21288196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent development of small molecular specific inhibitor of protein tyrosine phosphatase 1B.
    Lee S; Wang Q
    Med Res Rev; 2007 Jul; 27(4):553-73. PubMed ID: 17039461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation.
    Miao J; Zhang ZY
    ChemMedChem; 2024 Apr; 19(7):e202300669. PubMed ID: 38233347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of protein tyrosine phosphatases: next-generation drugs?
    Bialy L; Waldmann H
    Angew Chem Int Ed Engl; 2005 Jun; 44(25):3814-39. PubMed ID: 15900534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-based design and discovery of novel inhibitors of protein tyrosine phosphatases.
    Huang P; Ramphal J; Wei J; Liang C; Jallal B; McMahon G; Tang C
    Bioorg Med Chem; 2003 Apr; 11(8):1835-49. PubMed ID: 12659770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTPs emerge as PIPs: protein tyrosine phosphatases with lipid-phosphatase activities in human disease.
    Pulido R; Stoker AW; Hendriks WJ
    Hum Mol Genet; 2013 Oct; 22(R1):R66-76. PubMed ID: 23900072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allele-specific inhibitors of protein tyrosine phosphatases.
    Hoffman HE; Blair ER; Johndrow JE; Bishop AC
    J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring Allosteric Inhibitors of Protein Tyrosine Phosphatases Through High-Throughput Screening.
    Hayashi T; Hatakeyama M
    Methods Mol Biol; 2023; 2691():235-245. PubMed ID: 37355550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrating virtual and biochemical screening for protein tyrosine phosphatase inhibitor discovery.
    Martin KR; Narang P; Medina-Franco JL; Meurice N; MacKeigan JP
    Methods; 2014 Jan; 65(2):219-28. PubMed ID: 23969317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.